![(PDF) Population Pharmacokinetics of Clozapine and Norclozapine and Switchability Assessment between Brands in Uruguayan Patients with Schizophrenia (PDF) Population Pharmacokinetics of Clozapine and Norclozapine and Switchability Assessment between Brands in Uruguayan Patients with Schizophrenia](https://i1.rgstatic.net/publication/331577257_Population_Pharmacokinetics_of_Clozapine_and_Norclozapine_and_Switchability_Assessment_between_Brands_in_Uruguayan_Patients_with_Schizophrenia/links/618287a9a767a03c14eaa349/largepreview.png)
(PDF) Population Pharmacokinetics of Clozapine and Norclozapine and Switchability Assessment between Brands in Uruguayan Patients with Schizophrenia
![T helper 17 cells may drive neuroprogression in major depressive disorder: Proposal of an integrative model - ScienceDirect T helper 17 cells may drive neuroprogression in major depressive disorder: Proposal of an integrative model - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0149763415302037-fx1.jpg)
T helper 17 cells may drive neuroprogression in major depressive disorder: Proposal of an integrative model - ScienceDirect
![PDF) CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions PDF) CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions](https://i1.rgstatic.net/publication/249965518_CYP1A2_genetic_polymorphisms_are_associated_with_early_antidepressant_escitalopram_metabolism_and_adverse_reactions/links/54220f670cf238c6ea67851f/largepreview.png)